E25

Adrenogenital disorders

Header / non-billable

This code does not map to a risk-adjusting HCC in the loaded models.

Coding notes

Excludes 1 never coded together · Excludes 2 may co-exist

This code · E25
Includes

adrenogenital syndromes, virilizing or feminizing, whether acquired or due to adrenal hyperplasia consequent on inborn enzyme defects in hormone synthesis Female adrenal pseudohermaphroditism Female heterosexual precocious pseudopuberty Male isosexual precocious pseudopuberty Male macrogenitosomia praecox Male sexual precocity with adrenal hyperplasia Male virilization (female)

Excludes 1

indeterminate sex and pseudohermaphroditism (Q56) chromosomal abnormalities (Q90-Q99)

Inherited from E20-E35Disorders of other endocrine glands
Excludes 1

galactorrhea (N64.3) gynecomastia (N62)

Inherited from chapter 4Endocrine, nutritional and metabolic diseases
Excludes 1

transitory endocrine and metabolic disorders specific to newborn (P70-P74)

Note

All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.

Official Guidelines for E25

FY 2026 ›